JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB14613

Anti-PDE4D antibody

4

(2 Reviews)

|

(25 Publications )

Rabbit Polyclonal PDE4D antibody. Suitable for WB, IHC-P and reacts with Human samples. Cited in 25 publications.
3 Images
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-PDE4D antibody (AB14613)
  • IHC-P

Unknown

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-PDE4D antibody (AB14613)

ab14613 (2µg/ml) staining PDE4D in human placenta using an automated system (DAKO Autostainer Plus). Using this protocol there is strong staining of the cytoplasm.
Sections were rehydrated and antigen retrieved with the Dako 3 in 1 AR buffer EDTA pH 9.0 in a DAKO PT link. Slides were peroxidase blocked in 3% H2O2 in methanol for 10 mins. They were then blocked with Dako Protein block for 10 minutes (containing casein 0.25% in PBS) then incubated with primary antibody for 20 min and detected with Dako envision flex amplification kit for 30 minutes. Colorimetric detection was completed with Diaminobenzidine for 5 minutes. Slides were counterstained with Haematoxylin and coverslipped under DePeX. Please note that, for manual staining, optimization of primary antibody concentration and incubation time is recommended. Signal amplification may be required.

Western blot - Anti-PDE4D antibody (AB14613)
  • WB

Unknown

Western blot - Anti-PDE4D antibody (AB14613)

Western blot using ab14613 and positive controls for PDE4D variants.

All lanes:

Western blot - Anti-PDE4D antibody (ab14613)

Predicted band size: 91 kDa

false

Western blot - Anti-PDE4D antibody (AB14613)
  • WB

CiteAb

Western blot - Anti-PDE4D antibody (AB14613)

PDE4D western blot using anti-PDE4D antibody ab14613. Publication image and figure legend from Fang, Q., Ma, Y., et al., 2013, Mediators Inflamm, PubMed 24227907.

ab14613 was used in this publication in western blot. This may not be the same as the application(s) guaranteed by Abcam. For a full list of applications guaranteed by Abcam for ab14613 please see the product overview.

Effect of PGE2 and indomethacin on PDE4 expression. Confluent HFL-1 cells were treated with SF-DMEM with or without 10-9 M PGE2 or 10-6 M indomethacin for 24 hrs. Whole cell lysates were immunoblotted for PDE4 isoforms and β-actin as loading control. Images were visualized with ECL plus (a), and the bands from 3 separate experiments were quantified (b). *p < 0.05.

false

Key facts

Host species

Rabbit

Clonality

Polyclonal

Isotype

IgG

Carrier free

No

Reacts with

Human

Applications

WB, IHC-P

applications

Immunogen

The exact immunogen used to generate this antibody is proprietary information.

Specificity

ab14613 labels all PDE4D proteins including PDE4D1, PDE4D2, PDE4D3, PDE4D4, PDE4D5 variants. Does not cross react with PDE4A, PDE4B, PDE4D6, PDE4D7, PDE4D8, PDE4D9 or PDE4C. The antibody has not been tested against endogenous PDE4D, only recombinant proteins and we therefore cannot guarantee it will detect endogenous PDE4&#46;

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "", "WB-species-notes": "<p></p>", "IHCP-species-checked": "testedAndGuaranteed", "IHCP-species-dilution-info": "", "IHCP-species-notes": "<p></p>" } } }

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Immunogen
Storage buffer
Preservative: 0.02% Sodium azide
Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

Phosphodiesterase 4D (PDE4D) is an enzyme that hydrolyzes cyclic AMP (cAMP) to its inactive form AMP controlling important cellular signaling pathways. It is part of the large PDE family and sometimes referred to as DPDE1. With a molecular weight of approximately 93 kDa PDE4D is widely expressed in the brain heart lungs and immune cells. Its expression in these tissues indicates an important regulatory role in both central and peripheral physiological processes.
Biological function summary

PDE4D plays an important role in the modulation of intracellular cAMP levels impacting processes such as inflammation cognition and cardiac function. It does not operate as part of a larger complex but collaborates with other signaling molecules to influence cellular responses. PDE4D's regulation of cAMP levels directly affects protein kinase A (PKA) leading to alterations in gene expression and cell activity.

Pathways

PDE4D integrates into the cAMP signaling and inflammatory pathways impacting various cellular responses. In the cAMP signaling pathway it partners with other PDEs and signaling proteins such as PKA which phosphorylates target proteins affecting cellular function. In inflammatory pathways PDE4D modulates immune cell activity by altering the cAMP-mediated inhibition of pro-inflammatory cytokine production linking it to inflammation-related responses.

PDE4D has associations with conditions such as asthma and ischemic stroke. In asthma PDE4D regulates cAMP levels in lung cells affecting bronchial constriction and inflammation. In ischemic stroke alterations in PDE4D activity influence vascular function by changing cAMP dynamics in vascular smooth muscle cells. Within these disorders PDE4D interacts with proteins like cytokines and COX-2 which also play parts in inflammatory pathways and vascular responses.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Hydrolyzes the second messenger cAMP, which is a key regulator of many important physiological processes.
See full target information PDE4D

Alternative Names

DPDE3, PDE4D, PDE43, cAMP-specific phosphodiesterase 4D

Publications (25)

Recent publications for all applications. Explore the full listand refine your search

Journal of the American Heart Association 13:e033733 PubMed38860414

2024

Differential Downregulation of β-Adrenergic Receptor Signaling in the Heart.

Applications

Unspecified application

Species

Unspecified reactive species

Bing Xu,Sherif Bahriz,Victoria R Salemme,Ying Wang,Chaoqun Zhu,Meimi Zhao,Yang K Xiang

FEBS letters 598:1591-1604 PubMed38724485

2024

Beta-amyloid interacts with and activates the long-form phosphodiesterase PDE4D5 in neuronal cells to reduce cAMP availability.

Applications

Unspecified application

Species

Unspecified reactive species

Yuan Yan Sin,Ryan T Cameron,Melissa Schepers,Ruth MacLeod,Tom A Wright,Dean Paes,Daniel van den Hove,Emily Willems,Tim Vanmierlo,Jos Prickaerts,Connor M Blair,George S Baillie

Cellular and molecular life sciences : CMLS 80:178 PubMed37306762

2023

Ablation of specific long PDE4D isoforms increases neurite elongation and conveys protection against amyloid-β pathology.

Applications

Unspecified application

Species

Unspecified reactive species

Dean Paes,Melissa Schepers,Emily Willems,Ben Rombaut,Assia Tiane,Yevgeniya Solomina,Amy Tibbo,Connor Blair,Elka Kyurkchieva,George S Baillie,Roberta Ricciarelli,Chiara Brullo,Ernesto Fedele,Olga Bruno,Daniel van den Hove,Tim Vanmierlo,Jos Prickaerts

Science advances 9:eadd5799 PubMed36662864

2023

Whole-heart multiparametric optical imaging reveals sex-dependent heterogeneity in cAMP signaling and repolarization kinetics.

Applications

Unspecified application

Species

Unspecified reactive species

Jessica L Caldwell,I-Ju Lee,Lena Ngo,Lianguo Wang,Sherif Bahriz,Bing Xu,Donald M Bers,Manuel F Navedo,Julie Bossuyt,Yang K Xiang,Crystal M Ripplinger

Translational oncology 27:101582 PubMed36403504

2022

Human β-defensin-3 and nuclear factor-kappa B p65 synergistically promote the cell proliferation and invasion of oral squamous cell carcinoma.

Applications

Unspecified application

Species

Unspecified reactive species

Yongxiu Du,Yanlan Yang,Wenbo Zhang,Chenxi Yang,Pu Xu

Experimental & molecular medicine 54:1201-1213 PubMed35999453

2022

Phosphodiesterase 4D contributes to angiotensin II-induced abdominal aortic aneurysm through smooth muscle cell apoptosis.

Applications

Unspecified application

Species

Unspecified reactive species

Ran Gao,Wenjun Guo,Tianfei Fan,Junling Pang,Yangfeng Hou,Xiaohang Feng,Bolun Li,Weipeng Ge,Tianhui Fan,Tiantian Zhang,Jiakai Lu,He Jing,Mu Jin,Chen Yan,Jing Wang

Communications biology 5:81 PubMed35058564

2022

Phosphodiesterase 4D promotes angiotensin II-induced hypertension in mice via smooth muscle cell contraction.

Applications

Unspecified application

Species

Unspecified reactive species

Tianfei Fan,Yangfeng Hou,Weipeng Ge,Tianhui Fan,Xiaohang Feng,Wenjun Guo,Xiaomin Song,Ran Gao,Jing Wang

Molecular metabolism :101182 PubMed33549845

2021

Adipose tissue lipolysis is regulated by PAQR11 via altering protein stability of phosphodiesterase 4D.

Applications

Unspecified application

Species

Unspecified reactive species

Meiqin Huang,Yijun Lin,Lin Wang,Xue You,Shuo Wang,Jingyu Zhao,Meijuan Bai,Zixuan Li,Yan Chen

PloS one 15:e0231806 PubMed32817622

2020

Diabetes induced decreases in PKA signaling in cardiomyocytes: The role of insulin.

Applications

Unspecified application

Species

Unspecified reactive species

Craig A Eyster,Satoshi Matsuzaki,Maria F Newhardt,Jennifer R Giorgione,Kenneth M Humphries

Science signaling 11: PubMed30301787

2018

Preassembled GPCR signaling complexes mediate distinct cellular responses to ultralow ligand concentrations.

Applications

Unspecified application

Species

Unspecified reactive species

Srgjan Civciristov,Andrew M Ellisdon,Ryan Suderman,Cindy K Pon,Bronwyn A Evans,Oded Kleifeld,Steven J Charlton,William S Hlavacek,Meritxell Canals,Michelle L Halls
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com